Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Adriano Piris, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Starrett GJ, Thakuria M, Chen T, Marcelus C, Cheng J, Nomburg J, Thorner AR, Slevin MK, Powers W, Burns RT, Perry C, Piris A, Kuo FC, Rabinowits G, Giobbie-Hurder A, MacConaill LE, DeCaprio JA. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med. 2020 03 18; 12(1):30. PMID: 32188490.
    Citations:    
  2. Piris A, Sanchez DF, Fernandez-Nestosa MJ, Cañete-Portillo S, Campagnoli T, Gonzalez Stark L, Zarza P, Oneto S, Lezcano C, Rodriguez I, Velazquez EF, Mihm M, Cubilla AL. Topographical Evaluation of Penile Lichen Sclerosus Reveals a Lymphocytic Depleted Variant, Preferentially Associated With Neoplasia: A Report of 200 Cases. Int J Surg Pathol. 2020 Aug; 28(5):468-476. PMID: 31969038.
    Citations:    
  3. Cañete-Portillo S, Sanchez DF, Fernández-Nestosa MJ, Piris A, Zarza P, Oneto S, Gonzalez Stark L, Lezcano C, Ayala G, Rodriguez I, Hoang MP, Mihm MC, Cubilla AL. Continuous Spatial Sequences of Lichen Sclerosus, Penile Intraepithelial Neoplasia, and Invasive Carcinomas: A Study of 109 Cases. Int J Surg Pathol. 2019 Aug; 27(5):477-482. PMID: 30614356.
    Citations:    Fields:    
  4. Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M, Adriaens C, Radaelli E, Wolter P, Bechter O, Dummer R, Levesque M, Piris A, Frederick DT, Boland G, Flaherty KT, van den Oord J, Voet T, Aerts S, Lund AW, Marine JC. Toward Minimal Residual Disease-Directed Therapy in Melanoma. Cell. 2018 08 09; 174(4):843-855.e19. PMID: 30017245.
    Citations: 3     Fields:    
  5. Mooradian MJ, Reuben A, Prieto PA, Hazar-Rethinam M, Frederick DT, Nadres B, Piris A, Juneja V, Cooper ZA, Sharpe AH, Corcoran RB, Flaherty KT, Lawrence DP, Wargo JA, Sullivan RJ. A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma. Oncoimmunology. 2018; 7(5):e1423172. PMID: 29721378.
    Citations: 1     
  6. Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov. 2018 02; 8(2):196-215. PMID: 29101162.
    Citations: 4     Fields:    
  7. Rana J, Moy AP, Piris A, Smith GP. Lupus and scleroderma overlap features in a 28-year-old man with anti-PL-12 anti-synthetase syndrome. Dermatol Online J. 2017 Sep 15; 23(9). PMID: 29469721.
    Citations:    Fields:    Translation:Humans
  8. Prieto-Granada CN, Lezcano C, Scolyer RA, Mihm MC, Piris A. Lethal melanoma in children: a clinicopathological study of 12 cases. Pathology. 2016 Dec; 48(7):705-711. PMID: 27956274.
    Citations: 1     Fields:    Translation:Humans
  9. Shen CH, Kim SH, Trousil S, Frederick DT, Piris A, Yuan P, Cai L, Gu L, Li M, Lee JH, Mitra D, Fisher DE, Sullivan RJ, Flaherty KT, Zheng B. Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma. Nat Med. 2016 09; 22(9):1056-61. PMID: 27500726.
    Citations: 4     Fields:    Translation:HumansCells
  10. Sanchez DF, Rodriguez IM, Piris A, Cañete S, Lezcano C, Velazquez EF, Fernandez-Nestosa MJ, Mendez-Pena JE, Hoang MP, Cubilla AL. Clear Cell Carcinoma of the Penis: An HPV-related Variant of Squamous Cell Carcinoma: A Report of 3 Cases. Am J Surg Pathol. 2016 07; 40(7):917-22. PMID: 26848799.
    Citations: 1     Fields:    Translation:HumansCells
  11. Friedman AA, Amzallag A, Pruteanu-Malinici I, Baniya S, Cooper ZA, Piris A, Hargreaves L, Igras V, Frederick DT, Lawrence DP, Haber DA, Flaherty KT, Wargo JA, Ramaswamy S, Benes CH, Fisher DE. Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment. PLoS One. 2015; 10(10):e0140310. PMID: 26461489.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  12. Mochel MC, Hammond MR, Frederick DT, Alora-Palli MB, Piris A, Flaherty KT, Hoang MP. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients. J Am Acad Dermatol. 2015 Sep; 73(3):491-9.e2. PMID: 26190239.
    Citations: 1     Fields:    Translation:Humans
  13. Wanner M, Mihm MC, Farinelli WA, Doukas A, Zurakowski D, Piris A, Avram MM, Klein JA, Anderson RR. Use of Photodynamic Therapy and Sterile Water to Target Adipose Tissue. Dermatol Surg. 2015 Jul; 41(7):803-11. PMID: 26079592.
    Citations:    Fields:    Translation:Animals
  14. Mochel MC, Piris A, Nose V, Hoang MP. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations. Am J Clin Pathol. 2015 Jun; 143(6):901-4. PMID: 25972334.
    Citations: 4     Fields:    Translation:HumansCells
  15. Kim H, Frederick DT, Levesque MP, Cooper ZA, Feng Y, Krepler C, Brill L, Samuels Y, Hayward NK, Perlina A, Piris A, Zhang T, Halaban R, Herlyn MM, Brown KM, Wargo JA, Dummer R, Flaherty KT, Ronai ZA. Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation. Cell Rep. 2015 Jun 09; 11(9):1458-73. PMID: 26027934.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  16. Piris A, Mihm MC, Hoang MP. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Hum Pathol. 2015 Feb; 46(2):239-45. PMID: 25479927.
    Citations: 9     Fields:    Translation:Humans
  17. Mochel MC, Duncan LM, Piris A, Kraft S. Primary mucosal melanoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of thirty-two cases. Head Neck Pathol. 2015 Jun; 9(2):236-43. PMID: 25292260.
    Citations: 4     Fields:    Translation:Humans
  18. Fathi AT, Lin WM, Durazzo T, Piris A, Sadrzadeh H, Bernardo L, Borger DR, McAfee SL, Kroshinsky D, Chen YB. Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia. J Clin Oncol. 2016 Mar 10; 34(8):e70-2. PMID: 25024084.
    Citations: 1     Fields:    Translation:Humans
  19. Christman MP, Kerner JK, Cheng C, Piris A, Nepo AG, Sepehr A, Kroshinsky D. Rhabdomyosarcoma arising in a giant congenital melanocytic nevus. Pediatr Dermatol. 2014 Sep-Oct; 31(5):584-7. PMID: 24913904.
    Citations: 1     Fields:    Translation:Humans
  20. Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, Mitra D, Lo JA, Hodi FS, Freeman GJ, Bosenberg MW, McMahon M, Flaherty KT, Fisher DE, Sharpe AH, Wargo JA. Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cancer Immunol Res. 2014 Jul; 2(7):643-54. PMID: 24903021.
    Citations: 56     Fields:    Translation:HumansAnimalsCells
  21. Konieczkowski DJ, Johannessen CM, Abudayyeh O, Kim JW, Cooper ZA, Piris A, Frederick DT, Barzily-Rokni M, Straussman R, Haq R, Fisher DE, Mesirov JP, Hahn WC, Flaherty KT, Wargo JA, Tamayo P, Garraway LA. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 2014 Jul; 4(7):816-27. PMID: 24771846.
    Citations: 97     Fields:    Translation:HumansCells
  22. Lee JJ, Mochel MC, Piris A, Boussahmain C, Mahalingam M, Hoang MP. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases. Hum Pathol. 2014 May; 45(5):1078-83. PMID: 24746214.
    Citations: 4     Fields:    Translation:Humans
  23. Piris A, Peng Y, Boussahmain C, Essary LR, Gudewicz TM, Hoang MP. Cutaneous and mammary apocrine carcinomas have different immunoprofiles. Hum Pathol. 2014 Feb; 45(2):320-6. PMID: 24342430.
    Citations: 5     Fields:    Translation:Humans
  24. Simpson RM, Bastian BC, Michael HT, Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt MH, Esplin DG, Smedley RC, Piris A, Meuten DJ, Kiupel M, Lee CC, Ward JM, Dwyer JE, Davis BJ, Anver MR, Molinolo AA, Hoover SB, Rodriguez-Canales J, Hewitt SM. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res. 2014 Jan; 27(1):37-47. PMID: 24128326.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  25. Cooper ZA, Frederick DT, Juneja VR, Sullivan RJ, Lawrence DP, Piris A, Sharpe AH, Fisher DE, Flaherty KT, Wargo JA. BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology. 2013 Oct 01; 2(10):e26615. PMID: 24251082.
    Citations: 30     
  26. Corcoran RB, Rothenberg SM, Hata AN, Faber AC, Piris A, Nazarian RM, Brown RD, Godfrey JT, Winokur D, Walsh J, Mino-Kenudson M, Maheswaran S, Settleman J, Wargo JA, Flaherty KT, Haber DA, Engelman JA. TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma. Sci Transl Med. 2013 Jul 31; 5(196):196ra98. PMID: 23903755.
    Citations: 57     Fields:    Translation:HumansAnimalsCells
  27. Sullivan RJ, Lawrence DP, Wargo JA, Oh KS, Gonzalez RG, Piris A. Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma. N Engl J Med. 2013 Jul 11; 369(2):173-83. PMID: 23841733.
    Citations: 9     Fields:    Translation:HumansCells
  28. Palioura S, Piris A, Chodosh J. Conjunctivitis, fever, and tender skin nodules. JAMA Ophthalmol. 2013 Jun; 131(6):791, 792-3. PMID: 23764707.
    Citations:    Fields:    Translation:Humans
  29. Kapoor R, Piris A, Saavedra AP, Duncan LM, Nazarian RM. Wolf isotopic response manifesting as postherpetic granuloma annulare: a case series. Arch Pathol Lab Med. 2013 Feb; 137(2):255-8. PMID: 23368868.
    Citations: 4     Fields:    Translation:HumansCells
  30. Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, Lizée G, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013 Mar 01; 19(5):1225-31. PMID: 23307859.
    Citations: 207     Fields:    Translation:HumansCells
  31. Hung T, Piris A, Lobo A, Mihm MC, Sober AJ, Tsao H, Tanabe KK, Duncan LM. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol. 2013 Jan; 44(1):87-94. PMID: 22939951.
    Citations: 5     Fields:    Translation:HumansCells
  32. Piris A, Lobo AC, Duncan LM. Melanoma staging: where are we now? Dermatol Clin. 2012 Oct; 30(4):581-92, v. PMID: 23021047.
    Citations: 5     Fields:    Translation:Humans
  33. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012; 7(4):e35295. PMID: 22545102.
    Citations: 59     Fields:    Translation:Humans
  34. Hawryluk EB, Sober AJ, Piris A, Nazarian RM, Hoang MP, Tsao H, Mihm MC, Duncan LM. Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic. J Am Acad Dermatol. 2012 Oct; 67(4):727-35. PMID: 22521204.
    Citations: 3     Fields:    Translation:Humans
  35. Corcoran RB, Ebi H, Turke AB, Coffee EM, Nishino M, Cogdill AP, Brown RD, Della Pelle P, Dias-Santagata D, Hung KE, Flaherty KT, Piris A, Wargo JA, Settleman J, Mino-Kenudson M, Engelman JA. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov. 2012 Mar; 2(3):227-35. PMID: 22448344.
    Citations: 223     Fields:    Translation:HumansAnimalsCells
  36. Frangos JE, Duncan LM, Piris A, Nazarian RM, Mihm MC, Hoang MP, Gleason B, Flotte TJ, Byers HR, Barnhill RL, Kimball AB. Increased diagnosis of thin superficial spreading melanomas: A 20-year study. J Am Acad Dermatol. 2012 Sep; 67(3):387-94. PMID: 22153791.
    Citations: 6     Fields:    Translation:Humans
  37. Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, MacConaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA. RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol. 2012 Jan 20; 30(3):316-21. PMID: 22067401.
    Citations: 97     Fields:    Translation:Humans
  38. Chaux A, Pfannl R, Rodríguez IM, Barreto JE, Velazquez EF, Lezcano C, Piris A, Netto GJ, Cubilla AL. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases. Am J Surg Pathol. 2011 Apr; 35(4):553-62. PMID: 21399489.
    Citations: 2     Fields:    Translation:Humans
  39. Piris A, Mihm MC, Duncan LM. AJCC melanoma staging update: impact on dermatopathology practice and patient management. J Cutan Pathol. 2011 May; 38(5):394-400. PMID: 21385199.
    Citations: 12     Fields:    Translation:Humans
  40. Kpodzo DS, Calderwood MS, Ruchelsman DE, Abramson JS, Piris A, Winograd JM, Kotton CN. Primary subcutaneous Alternaria alternata infection of the hand in an immunocompromised host. Med Mycol. 2011 Jul; 49(5):543-7. PMID: 21299373.
    Citations: 3     Fields:    Translation:HumansAnimals
  41. Kormos WA, Wu CC, Branda JA, Piris A. Case records of the Massachusetts General Hospital. Case 35-2010. A 56-year-old man with cough, hypoxemia, and rash. N Engl J Med. 2010 Nov 18; 363(21):2046-54. PMID: 21083390.
    Citations: 1     Fields:    Translation:HumansAnimals
  42. Kolman O, Hoang MP, Piris A, Mihm MC, Duncan LM. Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists. J Am Acad Dermatol. 2010 Oct; 63(4):661-7. PMID: 20846568.
    Citations:    Fields:    Translation:Humans
  43. Tsao H, Tanabe KK, Lawrence DP, Piris A. Case records of the Massachusetts General Hospital. Case 30-2010. A 15-year-old boy with a recurrent skin lesion. N Engl J Med. 2010 Sep 30; 363(14):1352-60. PMID: 20879885.
    Citations:    Fields:    Translation:HumansCells
  44. Piris A, Scopsi L, Clemente C, Cetti Serbelloni F, Mihm MC, Hoang MP. Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas. Am J Dermatopathol. 2010 Aug; 32(6):586-92. PMID: 20534988.
    Citations: 2     Fields:    Translation:Humans
  45. Piris A, Lobo AZ, Moschella SL. Global dermatopathology: Hansen's disease--current concepts and challenges. J Cutan Pathol. 2010 Apr; 37 Suppl 1:125-36. PMID: 20482684.
    Citations: 1     Fields:    Translation:Humans
  46. Yang G, Thieu K, Tsai KY, Piris A, Udayakumar D, Njauw CN, Ramoni MF, Tsao H. Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis. Cancer Res. 2009 Dec 01; 69(23):9029-37. PMID: 19903842.
    Citations: 1     Fields:    Translation:HumansCells
  47. Patterson TF, Mackool BT, Gilman MD, Piris A. Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected]. N Engl J Med. 2009 Jul 16; 361(3):287-96. PMID: 19605834.
    Citations: 6     Fields:    Translation:HumansAnimals
  48. Piris A, Mihm MC. Progress in melanoma histopathology and diagnosis. Hematol Oncol Clin North Am. 2009 Jun; 23(3):467-80, viii. PMID: 19464597.
    Citations: 4     Fields:    Translation:HumansCells
  49. Nazarian RM, Kapur P, Rakheja D, Piris A, Duncan LM, Mihm MC, Hoang MP. Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol. 2009 Apr; 22(4):600-10. PMID: 19252473.
    Citations: 4     Fields:    Translation:Humans
  50. Edwards R, Guerry D, Piris A, Elenitsas R, Seykora J, Schuchter L, Mihm M, Xu X, Gimotty P. Phospho-ERK (pERK) and Ki67 expression as compared to thickness and mitotic rate (MR) as prognostic factors in patients with stage I/II melanomas. J Clin Oncol. 2008 May 20; 26(15_suppl):9020. PMID: 27950722.
    Citations:    
  51. Maccalli C, Nonaka D, Piris A, Pende D, Rivoltini L, Castelli C, Parmiani G. NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients. Clin Cancer Res. 2007 Dec 15; 13(24):7459-68. PMID: 18094430.
    Citations: 8     Fields:    Translation:HumansCells
  52. Sugiyama A, Sugiura M, Piris A, Tomita Y, Mihm MC. Apocrine cystadenoma and apocrine hidrocystoma: examination of 21 cases with emphasis on nomenclature according to proliferative features. J Cutan Pathol. 2007 Dec; 34(12):912-7. PMID: 18001413.
    Citations: 1     Fields:    Translation:Humans
  53. Piris A, Mihm MC. Mechanisms of metastasis: seed and soil. Cancer Treat Res. 2007; 135:119-27. PMID: 17953412.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  54. Hoon DS, Kitago M, Kim J, Mori T, Piris A, Szyfelbein K, Mihm MC, Nathanson SD, Padera TP, Chambers AF, Vantyghem SA, MacDonald IC, Shivers SC, Alsarraj M, Reintgen DS, Passlick B, Sienel W, Pantel K. Molecular mechanisms of metastasis. Cancer Metastasis Rev. 2006 Jun; 25(2):203-20. PMID: 16770533.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  55. Pilla L, Patuzzo R, Rivoltini L, Maio M, Pennacchioli E, Lamaj E, Maurichi A, Massarut S, Marchianò A, Santantonio C, Tosi D, Arienti F, Cova A, Sovena G, Piris A, Nonaka D, Bersani I, Di Florio A, Luigi M, Srivastava PK, Hoos A, Santinami M, Parmiani G. A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients. Cancer Immunol Immunother. 2006 Aug; 55(8):958-68. PMID: 16215718.
    Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
  56. Zanon M, Piris A, Bersani I, Vegetti C, Molla A, Scarito A, Anichini A. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents. Cancer Res. 2004 Oct 15; 64(20):7386-94. PMID: 15492260.
    Citations: 4     Fields:    Translation:HumansCells
  57. Velazquez EF, Barreto JE, Rodriguez I, Piris A, Cubilla AL. Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol. 2004 Apr; 12(2):139-46. PMID: 15173919.
    Citations: 5     Fields:    Translation:Humans
  58. Lugini L, Lozupone F, Matarrese P, Funaro C, Luciani F, Malorni W, Rivoltini L, Castelli C, Tinari A, Piris A, Parmiani G, Fais S. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest. 2003 Nov; 83(11):1555-67. PMID: 14615410.
    Citations: 22     Fields:    Translation:HumansCells
  59. Piris A, Rosai J. Pigmented lesions in unusual anatomic sites. Semin Diagn Pathol. 2003 Nov; 20(4):249-59. PMID: 14694978.
    Citations: 3     Fields:    Translation:HumansCells
  60. Mortarini R, Piris A, Maurichi A, Molla A, Bersani I, Bono A, Bartoli C, Santinami M, Lombardo C, Ravagnani F, Cascinelli N, Parmiani G, Anichini A. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res. 2003 May 15; 63(10):2535-45. PMID: 12750277.
    Citations: 36     Fields:    Translation:HumansCells
  61. Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchianò A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P, Parmiani G. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol. 2002 Oct 15; 20(20):4169-80. PMID: 12377960.
    Citations: 66     Fields:    Translation:HumansCellsCTClinical Trials
  62. Cubilla AL, Piris A, Pfannl R, Rodriguez I, Agüero F, Young RH. Anatomic levels: important landmarks in penectomy specimens: a detailed anatomic and histologic study based on examination of 44 cases. Am J Surg Pathol. 2001 Aug; 25(8):1091-4. PMID: 11474296.
    Citations: 3     Fields:    Translation:Humans
  63. Cubilla AL, Reuter V, Velazquez E, Piris A, Saito S, Young RH. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol. 2001 Apr; 9(2):111-20. PMID: 11484498.
    Citations: 13     Fields:    Translation:Humans
  64. Capella G, Piris AG. [The direction of positional nystagmus in vertiginous diseases]. Acta Otorhinolaryngol Belg. 1975; 29(1):173-81. PMID: 1211153.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Piris's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (348)
Explore
_
Co-Authors (81)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.